Predicted protein targets (top 15)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CES2 | O00748 | 4/20 | 0.50 |
| ▸ | MEN1 | O00255 | 1/20 | 0.47 |
| ▸ | FAAH | O00519 | 1/20 | 0.47 |
| ▸ | MAPK1 | P28482 | 1/20 | 0.47 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.47 |
| ▸ | CES1 | P23141 | 3/20 | 0.43 |
| ▸ | HSP90AA1 | P07900 | 1/20 | 0.42 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.42 |
| ▸ | TSHR | P16473 | 1/20 | 0.42 |
| ▸ | SLC22A6 | Q4U2R8 | 1/20 | 0.42 |
| ▸ | SLC22A8 | Q8TCC7 | 1/20 | 0.42 |
| ▸ | GPR84 | Q9NQS5 | 1/20 | 0.42 |
| ▸ | PPARG | P37231 | 1/20 | 0.42 |
| ▸ | PPARD | Q03181 | 1/20 | 0.42 |
| ▸ | PPARA | Q07869 | 1/20 | 0.42 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL30822642 | 0.87 | CES2 (0.52) | CES2MEN1FAAHMAPK1KMT2A | |
| SCHEMBL457605 | 0.86 | CES2 (0.47) | CES2MEN1FAAHMAPK1KMT2A | |
| SCHEMBL455074 | 0.86 | CES2 (0.47) | CES2MEN1FAAHMAPK1KMT2A | |
| Hydrochloric Acid SCHEMBL28951893 | 0.85 | CES2 (0.50) | CES2MEN1FAAHMAPK1KMT2A | |
| Hydrochloric Acid SCHEMBL16538160 | 0.84 | CES2 (0.46) | CES2MEN1FAAHMAPK1KMT2A | |
| SCHEMBL28521158 | 0.81 | CES2 (0.53) | CES2MEN1FAAHMAPK1KMT2A | |
| Sulfuric Acid SCHEMBL29052907 | 0.80 | NAAA (0.42) | CES2MEN1FAAHMAPK1KMT2A | |
| SCHEMBL5846756 | 0.80 | NAAA (0.42) | CES2MEN1FAAHMAPK1KMT2A | |
| Hydrochloric Acid SCHEMBL28916535 | 0.79 | CES2 (0.52) | CES2MEN1FAAHMAPK1KMT2A | |
| SCHEMBL28890616 | 0.78 | CES2 (0.59) | CES2MAPK1CES1ALDH1A1TSHR |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-8933134-B2 | Compositions containing agar and a softening agent | L'OREAL (FR) | 2015-01-13 | — | — | US | disclosed |
| US-20060034792-A1 | Cosmetic composition based on a cationic surfactant, an amino silicone or vinyl silicone, a fatty alcohol and a propellant | L'OREAL (FR) | 2006-02-16 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20060034792-A1 | Cosmetic composition based on a cationic surfactant, an amino silicone or vinyl silicone, a fatty alcohol and a propellant | PHOSPHO1, SGMS1, SGMS2 | CES2 1877/4885MEN1 902/4885FAAH 473/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.